| Literature DB >> 31847288 |
Eman Ramadan Mohamed1, Mamdouh Yones Ali1, Nancy G F M Waly2, Hamada Mohamed Halby1, Rehab Mahmoud Abd El-Baky2,3.
Abstract
The emergence of blaKPC-2 and blaNDM-1 producing Klebsiella pneumoniae represents a great problem in many Egyptian hospitals. One hundred and twenty-six K. pneumoniae isolates from patients admitted to Assiut University Hospital were identified by an API20E kit. Carbapenemase-producing K. pneumoniae (CPKP) was detected by the modified carbapenem inactivation method (mCIM), the EDTA-modified carbapenem inactivation method (eCIM), and an E-test. Based on the polymerase chain reaction, all isolates were negative for bla-VIM-1 and bla-IMP-1, fifteen of these isolates were positive for both blaKPC-2 and blaNDM-1, two isolates were positive for blaKPC-2 only, and twenty-eight isolates were positive for bla-NDM-1 only. Although one isolate was positive for the string test, all CPKP isolates were negative for capsular genes. Only 71.1% of CPKP transferred their plasmids to their corresponding transconjugants (E. coli J53). The resistance patterns of the clinical isolates and their transconjugates were similar, except for 12 isolates, which showed differences with their transconjugates in the resistance profile of four antibiotics. Molecular typing of the plasmids based on replicon typing showed that Inc FIIK and FII plasmids predominated in isolates and their transconjugants carrying blaKPC-2 and/or blaNDM-1. Conjugative Inc FII plasmids play an important role in the spread of CPKP, and their recognition is essential to limit their spread.Entities:
Keywords: Carbapenemase-producing Klebsiella pneumoniae; MβL; PBRT; blaKPC-2; blaNDM-1; eCIM; mCIM; plasmid replicon type hvCPKP
Year: 2019 PMID: 31847288 PMCID: PMC6963397 DOI: 10.3390/antibiotics8040266
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Resistance Pattern of Carbapenemase producing K. pneumoniae (CPKP).
Figure 2Prevalence of Carbapenemase genes and capsular genes among Carbapenemase producing K. pneumoniae (CPKP).
Phenotypic and genotypic methods for the detection of CPKP.
| Genotypic Method | No. of Isolates | Phenotypic Detection of Carbapenemase Producing Isolates | |
|---|---|---|---|
| mCIM No. (%) * | eCIM No. (%) * | ||
|
| 32 | 0 (0) | NT |
|
| 28 | 28 (100) | 9 (32.1) |
|
| 2 | 2 (100) | 2 (100) |
|
| 15 | 15 (100) | 5 (33.3) |
* Percentages were correlated to the number of isolates of each group. Group 1: Negative for all tested genes; Group 2: positive for bla- and negative for bla-KPC-2, bla-IMP-1 and bla-VIM-1. Group 3: positive for bla-KPC-2 and negative for bla-IMP-1, bla-VIM1 and bla- Group 4: positive for bla-KPC-2 and bla- and negative for bla-IMP-1, bla-VIM1. NT: Not tested, mCIM: modified carbapenemase inhibition method, eCIM: EDTA-modified carbapenemase inhibition method.
Resistance patterns of the 12 isolates and transconjugates showing different resistance profiles.
| Antibiotics | Tetracycline | Gentamicin | Sulfamethoxazole/Trimethoprim | Levofloxacin | |
|---|---|---|---|---|---|
| Strains | |||||
| KP3/transconjugate | R/S | R/S | R/S | R/R | |
| KP4/transconjugate | R/S | R/S | R/R | R/R | |
| KP5/transconjugate | R/R | R/S | R/S | R/R | |
| KP7/transconjugate | R/S | R/S | R/R | R/R | |
| KP9/transconjugate | R/S | R/S | R/R | R/R | |
| KP10/transconjugate | R/S | R/S | R/R | R/R | |
| KP15/transconjugate | R/S | R/R | S/S | R/R | |
| KP16/transconjugate | R/R | R/R | R/S | R/R | |
| KP19/transconjugate | R/S | R/R | R/R | R/S | |
| KP25/transconjugate | R/R | S/S | R/S | R/S | |
| KP28/transconjugate | R/R | R/S | R/S | R/R | |
| KP29/transconjugate | R/R | R/S | R/R | R/R | |
KP: K. pneumoniae, R: resistant, S: sensitive.
Relation between the plasmid replicon type and the transfer of resistant genes.
| Strain Code | Carbapenemase Gene | PBRT of Isolates | PBRT of Transconjugant |
|---|---|---|---|
| Kp1 | NDM-1, KPC-2 | FII | FII |
| KP2 | NDM1 | FIIK | FIIK |
| KP3 | NDM-1 | FII, FIIK, L | FIIK |
| KP4 | NDM-1 | M, L | - |
| KP5 | NDM-1 | - | - |
| KP6 | NDM-1, KPC-2 | - | - |
| KP7 | NDM-1 | FIB, M | - |
| KP8 | KPC-2 | FII, FIIK, FIB | FII, FIIK |
| KP9 | NDM-1 | FIIK, FIB | FIIK, FIB |
| KP10 | NDM-1 | FIIK, M | FIIK |
| KP11 | NDM-1 | FIC | - |
| KP12 | NDM-1 | FIIK, FIB, FII, M | FIIK, FIB |
| KP13 | NDM-1, KPC-2 | FIC | - |
| KP14 | NDM-1 | FIB, FIIK, FII, FIC | FIIK |
| KP15 | NDM-1 | FIC | - |
| KP16 | NDM-1, KPC-2 | FII, FIIK, FIB | FII, FIIK, FIB |
| KP17 | KPC-2 | FII, FIIK | - |
| KP18 | NDM-1, KPC-2 | FII, FIIK, FIB | FIIK |
| KP19 | NDM-1 | L | - |
| KP20 | NDM-1 | FIB | - |
| KP21 | NDM-1, KPC-2 | FII, FIIK, FIB | FII, FIIK, FIB |
| KP22 | NDM-1 | - | - |
| KP23 | NDM-1, KPC-2 | FII, FIIK, FIB, M | FII, FIIK, FIB |
| KP24 | NDM-1, KPC-2 | FIIK, FII, FIB, | FIIK |
| KP25 | NDM-1, KPC-2 | FII, FIIK | FII, FIIK |
| KP26 | NDM-1 | FIIK, FIB, L, M | FIB |
| KP27 | NDM-1 | L, M | - |
| KP28 | NDM-1 | FIC, FII, FIIK | FII |
| KP29 | NDM-1, KPC-2 | FIIK, FII | - |
| KP30 | NDM-1, KPC-2 | FIIK, FII, FIB | FIIK |
| KP31 | NDM-1, KPC-2 | FIIK, FII, M | FIIK |
| KP32 | NDM-1 | FIIK, FIC, FIB | FIIK |
KP: K. pneumoniae, KPC: Carbapenemase-producing K. pneumoniae, NDM: New Delhi-metallo beta-lactamase.